Correlation between Human Leukocyte Antigen Class II Alleles and HAI Titers Detected Post-Influenza Vaccination

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Moss, Alastair J ^a   Gaughran, Fiona P ^b   Karasu, Aliyye ^c   Gilbert, Anthony S ^d   Mann, Alex J ^d   Gelder, Colin M ^e   Oxford, John S ^e   Stephens, Henry A ^c   Lambkin Williams, Rob ^d  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; HLA A2 ANTIGEN; INFLUENZA VACCINE; VIRUS RNA;

ADULT; AGED; ALLELE; ANTIBODY TITER; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE FREQUENCY; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFLUENZA; MAJOR CLINICAL STUDY; MALE; PROTEIN ANALYSIS; PROTEIN FUNCTION; VACCINATION; VIRUS STRAIN;

EID: 84881234538     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071376     Document Type: Article

References (18)

1. Rivetti D, Jefferson T, Thomas R, Rudin M, Rivetti A, et al. (2006) Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev: CD004876.
2. Bridges CB, Fukuda K, Cox NJ, Singleton JA, (2001) Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 50: 1-44.
3. Poland GA, Ovsyannikova IG, Jacobson RM, (2008) Immunogenetics of seasonal influenza vaccine response. Vaccine 26Suppl 4: D35-40.
4. Delves PJ, Roitt IM, (2000) The immune system. Second of two parts. N Engl J Med 343: 108-117.
5. Gelder CM, Lambkin R, Hart KW, Fleming D, Williams OM, et al. (2002) Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine. J Infect Dis 185: 114-117.
6. de Jong JC, Palache AM, Beyer WE, Rimmelzwaan GF, Boon AC, et al. (2003) Haemagglutination-inhibiting antibody to influenza virus. Dev Biol (Basel) 115: 63-73.
7. Gaughran F, Walwyn R, Lambkin-Williams R, Whelan P, Chatterton K, et al. (2007) Flu: effect of vaccine in elderly care home residents: a randomized trial. J Am Geriatr Soc 55: 1912-1920.
8. Whelan PJ, Walwyn R, Gaughran F, Macdonald A, (2012) Impact of the demand for 'proxy assent' on recruitment to a randomised controlled trial of vaccination testing in care homes. J Med Ethics 0: 1-5.
9. Iovannisci DM, Ha TT, Shaw GM, (2006) Recovery of genomic DNA from residual frozen archival blood clots suitable for amplification and use in genotyping assays. Genet Test 10: 44-49.
10. Gerolami K LM (2001) HLA-DR Typing via LABtype and the Luminex LabMAP. Human Immunology 62.
11. Gebe JA, Novak EJ, Kwok WW, Farr AG, Nepom GT, et al. (2001) T cell selection and differential activation on structurally related HLA-DR4 ligands. J Immunol 167: 3250-3256.
12. Danke NA, Kwok WW, (2003) HLA class II-restricted CD4+ T cell responses directed against influenza viral antigens postinfluenza vaccination. J Immunol 171: 3163-3169.
13. Yang J, Gebe JA, Huston L, James E, Tan V, et al. (2009) H5N1 strain-specific hemagglutinin CD4+ T cell epitopes restricted by HLA DR4. Vaccine 27: 3862-3869.
14. Desombere I, Willems A, Leroux-Roels G, (1998) Response to hepatitis B vaccine: multiple HLA genes are involved. Tissue Antigens 51: 593-604.
15. Schuenke KW, Cook RG, Rich RR, (1998) Binding specificity of a class II-restricted hepatitis B epitope by DR molecules from responder and nonresponder vaccine recipients. Hum Immunol 59: 783-793.
16. Ohmit SE, Petrie JG, Cross RT, Johnson E, Monto AS, (2011) Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection. J Infec Dis 204: 1879-1885.
17. McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, et al. (2006) T cell responses are better correlates of vaccine protection in the elderly. J Immunol 176: 6333-6339.
18. Wilkinson TM, Li CK, Huang AK, Perkins M, Liebner JC, et al. (2012) Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med 18: 274-280.